AR008781A1 - Compuestos de furano nitrona - Google Patents

Compuestos de furano nitrona

Info

Publication number
AR008781A1
AR008781A1 ARP970103231A ARP970103231A AR008781A1 AR 008781 A1 AR008781 A1 AR 008781A1 AR P970103231 A ARP970103231 A AR P970103231A AR P970103231 A ARP970103231 A AR P970103231A AR 008781 A1 AR008781 A1 AR 008781A1
Authority
AR
Argentina
Prior art keywords
compounds
nitrona
furano
discovered
therapeutics
Prior art date
Application number
ARP970103231A
Other languages
English (en)
Original Assignee
Centaur Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centaur Pharmaceuticals Inc filed Critical Centaur Pharmaceuticals Inc
Publication of AR008781A1 publication Critical patent/AR008781A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/64—Sulfur atoms

Abstract

Se descubren compuestos de furano nitrona y composiciones farmacéuticas que contienen dichos compuestos. Los compuestos descubiertos son utiles comoreactivos analíticos para la deteccion de radicales libres y como terapéuticos para el trata miento de una amplia variedad de enfermedades y disfuncionesmédicas.
ARP970103231A 1996-07-19 1997-07-18 Compuestos de furano nitrona AR008781A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2216996P 1996-07-19 1996-07-19

Publications (1)

Publication Number Publication Date
AR008781A1 true AR008781A1 (es) 2000-02-23

Family

ID=21808169

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970103231A AR008781A1 (es) 1996-07-19 1997-07-18 Compuestos de furano nitrona

Country Status (16)

Country Link
US (4) US6376540B1 (es)
EP (1) EP1021430A1 (es)
JP (1) JP2000514822A (es)
KR (1) KR20000067915A (es)
AR (1) AR008781A1 (es)
AU (1) AU715226B2 (es)
CA (1) CA2260825A1 (es)
CO (1) CO4910142A1 (es)
HR (1) HRP970381A2 (es)
ID (1) ID19679A (es)
IL (1) IL128070A0 (es)
MA (1) MA26434A1 (es)
NZ (1) NZ333705A (es)
TN (1) TNSN97125A1 (es)
WO (1) WO1998003496A1 (es)
ZA (1) ZA976388B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW429241B (en) * 1996-09-26 2001-04-11 Sumitomo Pharma Nitrone derivatives
US5998469A (en) * 1998-01-16 1999-12-07 Centaur Pharmaceuticals, Inc. Thioether furan nitrone compounds
CN1136212C (zh) * 1998-01-16 2004-01-28 桑道药品有限公司 噻吩硝酮化合物
WO1999059579A1 (en) * 1998-05-19 1999-11-25 Centaur Pharmaceuticals, Inc. Furan nitrone therapeutics for the treatment of inflammatory bowel disease
AU750599B2 (en) 1998-07-17 2002-07-25 Renovis, Inc. Alpha-(2-hydroxyphenyl) nitrone compounds, pharmaceutical compositions containing the same and their use for treating inflammation
US6730700B2 (en) * 1998-12-02 2004-05-04 Renovis, Inc. 3,4,5,-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same
UA66401C2 (en) 1998-12-02 2004-05-17 Sentor Pharmaceuticals Inc 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical composition containing the same
EP1562975A2 (en) * 2002-10-25 2005-08-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
US20060166894A1 (en) * 2002-11-29 2006-07-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ace-inhibitors having antioxidant and no-donor activity
US20050059638A1 (en) * 2003-08-04 2005-03-17 Kelly Michael G. Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders
US20050182060A1 (en) * 2004-02-13 2005-08-18 Kelly Michael G. 2-Substituted and 4-substituted aryl nitrone compounds
US9034926B2 (en) 2010-12-30 2015-05-19 Nicholas V. Perricone Topical nitrone spin trap compositions for psoriasis
US8986739B2 (en) 2011-02-28 2015-03-24 Nicholas V. Perricone Treatment of urinary incontinence using nitrone spin traps

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3666754A (en) 1965-11-06 1972-05-30 Dainippon Pharmaceutical Co 2-(5-nitrofuryl) nitrone derivatives
US3988159A (en) 1967-07-28 1976-10-26 American Can Company Light-sensitive material containing nitrone for forming heat-fixed images
US3849934A (en) 1971-05-03 1974-11-26 Scm Corp Alpha-aryl-n-lower alkyl nitrone-containing compositions useful as anti-fungal agents
US3834073A (en) 1971-05-03 1974-09-10 Scm Corp Phenyl nitrone derivatives useful as seed protectants
US3950327A (en) 1972-09-19 1976-04-13 Ciba-Geigy Corporation New nitrones, their manufacture and their use for the manufacture of n-substituted araliphatic aldehyde-nitrones
US3917700A (en) 1974-01-30 1975-11-04 Goodyear Tire & Rubber Nitrone compounds
US3903049A (en) 1974-01-30 1975-09-02 Goodyear Tire & Rubber Oxidation resistant sulfur curable rubbery polymers
GB1588417A (en) 1977-03-15 1981-04-23 Agfa Gevaert Photoresist materials
US4153722A (en) 1977-10-06 1979-05-08 William H. Rorer, Inc. Method of treatment
GB2137619A (en) 1983-03-30 1984-10-10 Gerald Scott Nitrone compounds and stabilised rubber compositions containing them
US5352442A (en) 1985-07-18 1994-10-04 Proctor Peter H Topical tempo
US5723502A (en) 1985-07-18 1998-03-03 Proctor; Peter H. Topical spin trap composition and method
US4871862A (en) 1986-08-27 1989-10-03 Fisons Corporation α-Substituted ketonitrone derivatives
US4803282A (en) 1986-08-27 1989-02-07 Pennwalt Corporation Alpha-substituted ketonitrone derivatives
EP0327263B1 (en) 1988-01-29 1994-09-07 PROCTOR, Peter H. Hair growth stimulation with nitroxide and other radicals
JP2620413B2 (ja) * 1989-10-17 1997-06-11 オクラホマ メディカル リサーチ ファウンデーション 酸化的損傷に伴う疾患の阻止方法および組成物
ATE209908T1 (de) * 1991-06-18 2001-12-15 Oklahoma Med Res Found RADIKALFÄNGER (ßSPIN TRAPSß) ZUR BEHANDLUNG VON MIT OXIDATION VON LIPIDEN UND PROTEINEN VERBUNDENEN ERKRANKUNGEN
US5292746A (en) 1991-09-12 1994-03-08 Merrell Dow Pharmaceuticals Inc. Cyclic nitrones, pharmaceutical compositions thereof and their use in treating shock
GB9300894D0 (en) 1992-02-07 1993-03-10 Zeneca Ltd Oxime derivatives
US5455272A (en) 1993-10-22 1995-10-03 Oklahoma Medical Research Foundation Spin trap nitronyl hindered phenols
US5488145A (en) 1993-12-23 1996-01-30 Oklahoma Medical Research Foundation 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps
WO1997019054A1 (en) 1995-11-17 1997-05-29 Florida International University Azulenyl nitrone spin trapping agents, methods of making and using same
TW429241B (en) 1996-09-26 2001-04-11 Sumitomo Pharma Nitrone derivatives

Also Published As

Publication number Publication date
ID19679A (id) 1998-07-30
ZA976388B (en) 1998-02-19
HRP970381A2 (en) 1998-08-31
US6051571A (en) 2000-04-18
MA26434A1 (fr) 2004-12-20
US5942507A (en) 1999-08-24
NZ333705A (en) 2000-09-29
CO4910142A1 (es) 2000-04-24
WO1998003496A1 (en) 1998-01-29
JP2000514822A (ja) 2000-11-07
US6376540B1 (en) 2002-04-23
AU715226B2 (en) 2000-01-20
US6040444A (en) 2000-03-21
EP1021430A1 (en) 2000-07-26
CA2260825A1 (en) 1998-01-29
AU3655597A (en) 1998-02-10
TNSN97125A1 (fr) 2005-03-15
KR20000067915A (ko) 2000-11-25
IL128070A0 (en) 1999-11-30

Similar Documents

Publication Publication Date Title
ES2144192T3 (es) Nuevos derivados de 1-fenil-2-dimetil-amino-metil-ciclohexan-1-ol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
AR001413A1 (es) Compuestos triciclicos de carbamato, utiles para la inhibición de la función de la proteina g y paratratamiento de enfermedades proliferativas.
GT199700079A (es) Derivados triciclos sustituidos con fenilamino
ECSP055609A (es) "Uso de inhibidores de la IkB-quinasa para el tratamiento del dolor"
AR025960A1 (es) Biblioteca de sustancias que contiene imidazo-5-il-aminas biciclicas y/o imidazo 3-il-aminas biciclicas, procedimiento para la preparacion de estabiblioteca de sustancias, y uso de sustancias de esta biblioteca para la preparacion de medicamentos para el tratamiento del dolor
CR6392A (es) Moduladores de ccr5
ES2145774T3 (es) Derivados de adenosina que tienen actividad agonista en a2.
AR008781A1 (es) Compuestos de furano nitrona
GT199700089A (es) Derivados 6.6 o 6.7 -biciclicos sustituidos que contienen pirido o pirimido.
PA8468401A1 (es) Compuestos para el tratamiento de la isquemia
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
ES2186783T3 (es) Derivados de la dolastatina, su preparacion y uso.
SV1999000016A (es) Derivados de 2-(purin-9-il-tetrahidrofuran-3,4-diol ref. pg3443/sv
SV1996000114A (es) Nuevos plaguicidas
ES2157027T3 (es) Oxazolidinonas sustituidas y su uso como farmacos antibacterianos.
ES2075050T3 (es) Peptidos que tienen actividad cooperadora de celulas t.
ES2037013T3 (es) Procedimiento para preparar tieno-1,4-diazepinas.
ES2158327T3 (es) Derivados de benzo(g)quinolina.
ECSP034442A (es) Mezclas de polisacaridos derivados de la heparina, su preparacion y las composiciones farmaceuticas que las contienen
ES2163538T3 (es) Derivados de 3-oxo y 3-tioxo-4-aza-androstano diastereomericamente puros y su uso como antiandrogenos.
AR018162A1 (es) Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica
ES2183923T3 (es) Derivados de cromona.
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
AR028947A1 (es) Compuestos novedosos
ES2140672T3 (es) Compuestos biciclicos sustituidos, fusionados y puentes utilizados como agentes terapeuticos.